Showing results (1481-1490 of 1,702) with videos related to

Sort By:
Pageof 171
BMJ Open|November 14, 2019
Randomised clinical trial of an emergency department-based peer recovery support intervention to increase treatment uptake and reduce recurrent overdose among individuals at high risk for opioid overdose: study protocol for the navigator trialWilliam C Goedel, Brandon D L Marshall, Elizabeth A Samuels, et al.
Cancers|May 28, 2020
WRN-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic PhenotypeKai Zimmer, Alberto Puccini, Joanne Xiu, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 9, 2026
Medicinal cannabis plant extract (NTI164) modifies epigenetic, ribosomal, and immune pathways in paediatric acute-onset neuropsychiatric syndromeBrooke A Keating, Velda X Han, Hiroya Nishida, et al.
Nature Chemistry|July 22, 2016
Diindeno-fusion of an anthracene as a design strategy for stable organic biradicalsGabriel E Rudebusch, José L Zafra, Kjell Jorner, et al.
Clinical and Translational Science|July 25, 2018
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist TherapyHwa-Ping Feng, Zifang Guo, Luzelena Caro, et al.
Pediatrics|December 16, 2025
Improving Emergency Department Boarding Time: Balancing Efficiency and SafetyAdam A Vukovic, Tricia Purcell, Stephanie Thomas, et al.
Cancer|May 10, 2012
A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignanciesMichael J Pishvaian, John L Marshall, Andrew J Wagner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2020
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT databaseM E Salem, J Yin, R M Goldberg, et al.
Cancer Chemotherapy and Pharmacology|September 28, 2012
A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapyMichael J Pishvaian, Rebecca Slack, Eunice Y Koh, et al.
Gynecologic Oncology|October 17, 2018
Germline pathogenic variants identified in women with ovarian tumorsNatalie J Carter, Megan L Marshall, Lisa R Susswein, et al.
Pageof 171